Prolonged dermatitis distant to the site of squaric acid dibutyl ester applications and recovery of alopecia areata [2]

Clinical and Experimental Dermatology

Volumn 30, Issue 5, 2005, Pages 579-580

  Ujiie, H ^a   Sawamura, D ^a   Shibaki, A ^a   Shimizu, H ^a  

^a HOKKAIDO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; SQUARIC ACID DIBUTYL ESTER;

ADULT; ALOPECIA AREATA; CASE REPORT; CONTACT SENSITIVITY; CRYOTHERAPY; DERMATITIS; FEMALE; HUMAN; IMMUNOTHERAPY; LETTER; PRIORITY JOURNAL; TREATMENT OUTCOME;

ADMINISTRATION, CUTANEOUS; ADULT; ALOPECIA AREATA; CYCLOBUTANES; DRUG ERUPTIONS; FEMALE; HUMANS;

EID: 23044502239     PISSN: 03076938     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2230.2005.01804.x     Document Type: Letter

References (5)

1. Case P, Mitchell A, Swanson N et al. Topical therapy of alopecia areata with squaric acid dibutylester. J Am Acad Dermatol 1984; 10: 447-511.
2. Micali G, Licastro-Cicero R, Nasca MR et al. Treatment of alopecia areata with squaric acid dibutylester. Int J Dermatol 1996; 35: 52-6.
3. Caserio RJ. Treatment of alopecia areata with squaric acid dibutylester. Arch Dermatol 1987; 123: 1036-413.
4. Brocker EB, Echternacht-Happle K, Hamm H, Happle R. Abnormal expression of class I and class II major histocompatibility antigens in alopecia areata: modulation by topical immunotherapy. J Invest Dermatol 1987; 88: 564-8.
5. Zoller M, Freyschmidt-Paul P, Vitacolonna M et al. Chronic delayed-type hypersensitivity reaction as a means to treat alopecia areata. Clin Exp Immunol 2004; 135: 398-408.